The expression of SP263 in muscle invasive bladder carcinoma and its relationship with clinicopathological features
Context: The expression of programmed cell death ligand1 (PDL1) is a research hotspot of immunotherapy. The treatment targeted for its expression has shown effectiveness in many tumors. Objective: The aim of the study was to determine PD-L1 expression in urothelial carcinoma (UC) and to compare the...
Saved in:
Main Authors: | Yanfeng Bai (Author), Xuesong Wu (Author), Menghan Weng (Author), Qingmei Han (Author), Liming Xu (Author), Chengdong Chang (Author), Xiaodong Teng (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PD-L1 expression in muscle invasive urothelial carcinoma: Comparison of SP142 and SP263 assay
by: Gurudutt Gupta, et al.
Published: (2022) -
Invasive micropapillary carcinoma of urinary bladder: A clinicopathological study
by: Debajyoti Chatterjee, et al.
Published: (2015) -
26,3%
by: Mercedes Ruiz Paz
Published: (2004) -
Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer
by: Jillian Marie Walker, et al.
Published: (2022) -
External quality assessment demonstrates that PD‐L1 22C3 and SP263 assays are systematically different
by: Andrew Dodson, et al.
Published: (2020)